RxDoctor Payments Data

Kenneth Mroczek, MD

Orthopaedic Surgery · New York, NYNPI 1407842818

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $24,425 of the $27,889 with a category attached, or 87.6%. Extremity Medical accounts for 92.5% of it on its own, with 5 other manufacturers making up the rest.

$27,889in general payments, 2019–2025

Across 41 payments — averaging $680.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Extremity Medical$26K
  • Gotham Surgical Solutions & Devices, Inc.$1K
  • Integra Lifesciences Corporation$500
  • Stryker$340
  • Smith+Nephew$132
  • Linvatec Corporation$90
$748in research payments, 2019–2025

Across 1 payment — averaging $748.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$748

What the payments were for

  • Royalty or licence$24,42588%
  • Travel & lodging$1,2915%
  • Food & beverage$1,1534%
  • Education$1,0204%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,889 in reported general payments places this provider in the 75th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$28,851
Medicare patients
130
Services billed
201

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →